Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7525097

COC(=O)N1CCc2[nH]cnc2C1c1ccccc1.O=C(O)C(F)(F)F

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 3/20 0.48
RAB9A P51151 2/20 0.39
P2RX7 Q99572 1/20 0.37
ESR1 P03372 1/20 0.37
ESR2 Q92731 1/20 0.37
TRPV1 Q8NER1 1/20 0.36
HRH4 Q9H3N8 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
TRPM8 Q7Z2W7 3/20 0.35
ALDH1A1 P00352 2/20 0.34
POLB P06746 1/20 0.34
NPC1 O15118 1/20 0.33
MITF O75030 1/20 0.33
LMNA P02545 1/20 0.33
XBP1 P17861 1/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HHAT Q5VTY9 1/20 0.33
TP53 P04637 1/20 0.33
RBP4 P02753 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7570585 0.88 AOC3 (0.44) AOC3RAB9AP2RX7ESR1ESR2
SCHEMBL7570588 0.86 AOC3 (0.46) AOC3RAB9AP2RX7ESR1ESR2
Trifluoroacetic Acid SCHEMBL7529917 0.86 AOC3 (0.52) AOC3
Trifluoroacetic Acid SCHEMBL7530058 0.86 AOC3 (0.43) AOC3RAB9AP2RX7ESR1ESR2
Trifluoroacetic Acid SCHEMBL7530824 0.84 AOC3 (0.48) AOC3RAB9AP2RX7ALDH1A1NPC1
SCHEMBL7527434 0.81 AOC3 (0.63) AOC3RAB9AESR1ESR2TRPV1
SCHEMBL7527430 0.81 AOC3 (0.52) AOC3RAB9ATRPV1ALDH1A1POLB
Trifluoroacetic Acid SCHEMBL7530146 0.81 AOC3 (0.45) AOC3P2RX7HRH4HRH3ALDH1A1
SCHEMBL11515027 0.80 AOC3 (0.47) AOC3RAB9ATRPV1TRPM8HHAT
Trifluoroacetic Acid SCHEMBL7525401 0.79 AOC3 (0.43) AOC3HRH4HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020198189-A1 Treatment or prophylaxis of Semicarbazide-sensitive amine oxidase (SSAO) mediated complications in mammals including humans BIOVITRUM AB (SE) 2002-12-26 US disclosed
WO-2002038153-A1 NEW USE OF 4, 5, 6, 7-TETRAHYDROIMIDAZO-[4,5-C]PYRIDINE DERIVATIVES BIOVITRUM AB (SE) 2002-05-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020198189-A1 Treatment or prophylaxis of Semicarbazide-sensitive amine oxidase (SSAO) mediated complications in mammals including humans AOC3, AOC2, AOC1 AOC3 1/4885RAB9A 3795/4885P2RX7 2655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.